Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Pancreas. 2021 Sep 1;50(8):1123–1130. doi: 10.1097/MPA.0000000000001888

TABLE 5.

Prevalence of Pancreatic Cancer in Melanoma-prone Families for 10 Pathogenic CDKN2A Variants

No. Families Variant* No. Families With a Member Affected With PDAC
21 p.A76fs >60%
19 p.M53I <11%
16 p.G101W 35% to 50%
11 p.R112_L113insR >60%
11 c.−34G>T 15% to 25%
11 c.IVIS2–105A>G <11%
9 p.R24P 15% to 25%
7 p.V126D 35% to 50%
6 p.L32P 35% to 50%
6 c.32_33ins9–32 <11%
*

Variant position given in reference to NP_000068.1 for protein change (p.) and NM_000077.4 for transcript change (c.). PDAC – pancreatic adenocarcinoma.